Literature DB >> 29704630

Knockdown of NUP160 inhibits cell proliferation, induces apoptosis, autophagy and cell migration, and alters the expression and localization of podocyte associated molecules in mouse podocytes.

Ping Wang1, Feng Zhao2, Xiaojing Nie2, Jiewei Liu3, Zihua Yu4.   

Abstract

Genetic mutations in dozens of monogenic genes can lead to serious podocyte dysfunction, which is a major cause of steroid-resistant nephrotic syndrome (SRNS). The NUP160 gene is expressed in both human kidney and mouse kidney. However, whether knockdown of NUP160 impairs podocytes has not yet been established. Therefore, we knocked down NUP160 by targeted short hairpin RNA (shRNA) in conditionally immortalized mouse podocytes and observed the effect of NUP160 knockdown on the proliferation, apoptosis, autophagy and cell migration of podocytes. We also investigated the effect of NUP160 knockdown on the expression and localization of podocyte associated molecules, such as nephrin, podocin, CD2AP and α-actinin-4. The knockdown of NUP160 significantly inhibited the proliferation of podocytes by decreasing the expression of both cyclin D1 and CDK4, increasing the expression of p27, and inducing S phase arrest. The knockdown of NUP160 promoted the apoptosis and autophagy of podocytes, and enhanced cell migration. The knockdown of NUP160 decreased the expression of nephrin, podocin and CD2AP in podocytes, and increased the expression of α-actinin-4. The knockdown of NUP160 also altered the subcellular localization of nephrin, podocin and CD2AP in podocytes. These results suggest that the knockdown of NUP160 impairs mouse podocytes, i.e. inhibiting cell proliferation, inducing apoptosis, autophagy and cell migration of mouse podocytes, and altering the expression and localization of podocyte associated molecules, including nephrin, podocin, CD2AP and α-actinin-4.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  NUP160; Nucleoporin; Podocyte; Podocyte associated molecules

Mesh:

Substances:

Year:  2018        PMID: 29704630     DOI: 10.1016/j.gene.2018.04.067

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  NUP160 knockdown inhibits the progression of diabetic nephropathy in vitro and in vivo.

Authors:  Jiayong Xie; Zhi Chen; Gang Yao; Ying Yuan; Wenjuan Yu; Qiang Zhu
Journal:  Regen Ther       Date:  2022-06-17       Impact factor: 3.651

2.  Moderate Nucleoporin 133 deficiency leads to glomerular damage in zebrafish.

Authors:  Chiara Cianciolo Cosentino; Alessandro Berto; Stéphane Pelletier; Michelle Hari; Johannes Loffing; Stephan C F Neuhauss; Valérie Doye
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

3.  oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.

Authors:  Yuan Chen; Zhiyi Wang; Qian Li; Lichun Yu; Yanji Zhu; Jing Wang; Shuzhen Sun
Journal:  Mol Med Rep       Date:  2020-06-30       Impact factor: 2.952

4.  Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy.

Authors:  Jiayong Xie; Ying Yuan; Gang Yao; Zhi Chen; Wenjuan Yu; Qiang Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  CircHECTD1 mediates pulmonary fibroblast activation via HECTD1.

Authors:  Han Chu; Wei Wang; Wei Luo; Wei Zhang; Yusi Cheng; Jie Huang; Jing Wang; Xiaoniu Dai; Shencun Fang; Jie Chao
Journal:  Ther Adv Chronic Dis       Date:  2019-11-27       Impact factor: 5.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.